INTERFERON-α ACUTELY IMPAIRS SLEEP IN HEALTHY HUMANS

Author: Späth-Schwalbe E.   Lange T.   Perras B.   Lorenz Fehm H.   Born J.  

Publisher: Academic Press

ISSN: 1043-4666

Source: Cytokine, Vol.12, Iss.5, 2000-05, pp. : 518-521

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

We investigated the effects of two low doses of interferon-α (IFN-α) on nocturnal sleep in 18 healthy men by means of polysomnographic sleep recordings. At 1900h, human recombinant IFN-α (1000 or 10 000 U/kg body weight) or placebo was administered subcutaneously. Between 2300h and 0700h subjects were allowed to sleep. In general effects were stronger at the dose of 10 000 than 1000 U/kg body weight of IFN-α. Although, after IFN-α subjects experienced increased fatigue, the cytokine impaired the quality of nocturnal sleep. The higher dose of IFN-α suppressed slow wave sleep (17.8±2.0% vs 25.2±2.6% following placebo, P<0.003) but increased time spent in shallow sleep (P<0.05) during the first half of sleep time. Rapid eye movement (REM) sleep latency was postponed (P<0.02) and time spent in REM sleep was significantly decreased after IFN-α (P<0.04). The impairing influence of IFN-α on sleep in humans is in contrast with findings of sleep promoting effects of this cytokine in animals. Our data suggest that endogenous IFN-α may be a factor responsible for alterations of sleep, e.g. in the course of viral infections.

Related content